# PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns

> **NCT03079167** · PHASE3 · COMPLETED · sponsor: **University of Sydney** · enrollment: 313 (actual)

## Conditions studied

- Hypoxic-Ischemic Encephalopathy

## Interventions

- **DRUG:** Epoetin Alfa
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03079167
- **Lead sponsor:** University of Sydney
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-14
- **Primary completion:** 2023-11-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 313 (ACTUAL)
- **Last updated:** 2024-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03079167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03079167, "PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03079167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*